573 related articles for article (PubMed ID: 18097461)
41. 5'-(RACE) identification of rare ALK fusion partner in anaplastic large cell lymphoma.
Reading NS; Jenson SD; Smith JK; Lim MS; Elenitoba-Johnson KS
J Mol Diagn; 2003 May; 5(2):136-40. PubMed ID: 12707379
[No Abstract] [Full Text] [Related]
42. ALK-positive anaplastic large T-cell lymphoma preceded by Epstein-Barr virus infection complicated by development of an aorto-esophageal fistula.
Bagshaw SM; Crabtree T; Green F; Stewart DA
Leuk Lymphoma; 2002 Apr; 43(4):915-8. PubMed ID: 12153187
[TBL] [Abstract][Full Text] [Related]
43. Potential therapies for anaplastic lymphoma kinase-driven tumors in children: progress to date.
Lowe EJ; Lim MS
Paediatr Drugs; 2013 Jun; 15(3):163-9. PubMed ID: 23696342
[TBL] [Abstract][Full Text] [Related]
44. A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma.
Adélaïde J; Pérot C; Gelsi-Boyer V; Pautas C; Murati A; Copie-Bergman C; Imbert M; Chaffanet M; Birnbaum D; Mozziconacci MJ
Leukemia; 2006 Mar; 20(3):536-7. PubMed ID: 16424865
[No Abstract] [Full Text] [Related]
45. Jak3 contributes to the activation of ALK and Stat3 in ALK(+) anaplastic large cell lymphoma.
Amin HM; Lin Q; Lai R
Lab Invest; 2006 Apr; 86(4):417-9; author reply 420-1. PubMed ID: 16554750
[No Abstract] [Full Text] [Related]
46. Anaplastic Lymphoma Kinase: role in specific tumours, and development of small molecule inhibitors for cancer therapy.
Ardini E; Magnaghi P; Orsini P; Galvani A; Menichincheri M
Cancer Lett; 2010 Dec; 299(2):81-94. PubMed ID: 20934803
[TBL] [Abstract][Full Text] [Related]
47. A case of ALK-positive large T-cell lymphoma expressing epithelial membrane antigen with favorable prognosis.
Sawatsubashi M; Fukushima N; Satoh T; Tsuda K; Shin T; Tokunaga O
Acta Haematol; 1999; 102(1):47-50. PubMed ID: 10473888
[TBL] [Abstract][Full Text] [Related]
48. ALK-positive diffuse large B-cell lymphoma of the stomach associated with a clathrin-ALK rearrangement.
McManus DT; Catherwood MA; Carey PD; Cuthbert RJ; Alexander HD
Hum Pathol; 2004 Oct; 35(10):1285-8. PubMed ID: 15492998
[TBL] [Abstract][Full Text] [Related]
49. Mature T-cell and NK-cell lymphomas in the pediatric age group.
Jaffe ES
Am J Clin Pathol; 2004 Dec; 122 Suppl():S110-21. PubMed ID: 15690647
[TBL] [Abstract][Full Text] [Related]
50. Nodal ALK positive anaplastic large cell lymphoma of the axilla with spontaneous regression.
Patel P; Godwin J; Velankar M; Alkan S
Leuk Lymphoma; 2007 Jun; 48(6):1250-2. PubMed ID: 17577798
[No Abstract] [Full Text] [Related]
51. [Significance of ALK gene expression in neoplasms and normal tissues].
Shao CK; Su ZL; Feng ZY; Rao HL; Tang LY
Ai Zheng; 2002 Jan; 21(1):58-62. PubMed ID: 12500399
[TBL] [Abstract][Full Text] [Related]
52. Differential expression of aurora-A kinase in T-cell lymphomas.
Kanagal-Shamanna R; Lehman NL; O'Donnell JP; Lim MS; Schultz DS; Chitale DA; Bueso-Ramos CE; Medeiros LJ; Inamdar KV
Mod Pathol; 2013 May; 26(5):640-7. PubMed ID: 23411487
[TBL] [Abstract][Full Text] [Related]
53. Targeting the oncogenic tyrosine kinase NPM-ALK in lymphoma: the role of murine models in defining pathogenesis and treatment options.
Miething C; Peschel C; Duyster J
Curr Drug Targets; 2006 Oct; 7(10):1329-34. PubMed ID: 17073594
[TBL] [Abstract][Full Text] [Related]
54. A crucial role for the Anaplastic lymphoma kinase receptor tyrosine kinase in gut development in Drosophila melanogaster.
Lorén CE; Englund C; Grabbe C; Hallberg B; Hunter T; Palmer RH
EMBO Rep; 2003 Aug; 4(8):781-6. PubMed ID: 12855999
[TBL] [Abstract][Full Text] [Related]
55. [Updates on lymphoma pathology].
Zhu XZ; Li XQ
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):721-3. PubMed ID: 20079008
[No Abstract] [Full Text] [Related]
56. Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex.
Palacios G; Shaw TI; Li Y; Singh RK; Valentine M; Sandlund JT; Lim MS; Mullighan CG; Leventaki V
Leukemia; 2017 Mar; 31(3):743-747. PubMed ID: 27840423
[No Abstract] [Full Text] [Related]
57. ALK is not expressed in Hodgkin disease.
Camilleri-Broët S; Audouin J; Fermé C; Brière J; Pulford K; Gaulard P; Diviné M; Macintyre E; Delsol G; Berger F
Blood; 2001 Mar; 97(6):1901-2. PubMed ID: 11263444
[No Abstract] [Full Text] [Related]
58. Clinicopathological correlation, p16-p15 methylation status and outcome predictors in anaplastic large cell lymphoma.
García MJ; Castrillo JM; Granizo JJ; Cazorla A; Rivas C
Br J Haematol; 2002 Dec; 119(3):877-8. PubMed ID: 12437676
[No Abstract] [Full Text] [Related]
59. Primary pancreatic anaplastic large cell lymphoma, ALK negative: a case report.
Savopoulos CG; Tsesmeli NE; Kaiafa GD; Zantidis AT; Bobos MT; Hatzitolios AI; Papavramidis ST; Kostopoulos IS
World J Gastroenterol; 2005 Oct; 11(39):6221-4. PubMed ID: 16273656
[TBL] [Abstract][Full Text] [Related]
60. [Initial leukemic phase of ALK+ anaplastic large T-cell lymphoma, small cell variant].
André-Kerneïs E; Atassi-Abarah W; Ammar NA; Soussain C; Jeandel R; Allard C; Vincenot A
Ann Biol Clin (Paris); 2002; 60(1):85-8. PubMed ID: 11830398
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
